标题 |
[高分] 2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bioanalysis by Multiple Platforms; Super Sensitive ADA/NAb LBA ( PART 2A – Recommendations on Advanced Strategies for Biomarkers, IVD/CDx Assays (BAV), Cell Based Assays (CBA), and Ligand-Binding Assays (LBA) PART 2B – Regulatory Agencies’ Input on Biomarkers, IVD/CDx, and Biomarker Assay Validation)
2024年生物分析近期问题白皮书:美国LDT和欧盟IVDR的影响;用于高参数流式细胞术的AI/ML;Olink技术的崛起;用于AAV基因疗法的CDx;多平台综合生物分析;超灵敏ADA/NAb LBA(第2A部分-关于生物标志物、IVD/CDx检测(BAV)、基于细胞的检测(CBA)和配体结合检测(LBA)的高级策略的建议第2B部分-监管机构对生物标志物、IVD/CDx和生物标志物检测验证的意见)
|
网址 | |
DOI | |
其它 |
期刊:Bioanalysis 作者:Nicoletta Bivi; Danielle Graham; Laura Joglekar; Kristina McGuire; Jeroen Stoop; et al 出版日期:2025 |
求助人 | |
下载 | 求助已完成,仅限求助人下载。 |